Holen Sie sich die Stockscreener-App
1.29
3.64%
-0.0487
Handel nachbörslich:
1.29
AIM ImmunoTech Inc Aktie (AIM) Neueste Nachrichten
AIM ImmunoTech (NYSEAMERICAN:AIM) Upgraded at Zacks Research - Defense World
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Rate Cut: Is AIM ImmunoTech Inc HXB stock undervalued after correctionMarket Activity Summary & Free Expert Verified Stock Movement Alerts - moha.gov.vn
AIM ImmunoTech Inc.: - MarketScreener
Why AIM ImmunoTech Inc. (HXB) stock gets analyst attentionRisk Management & Safe Entry Trade Signal Reports - ulpravda.ru
Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
AIM ImmunoTech: One Shr for Every 1,000 Shrs or for Every Outstanding Option or Warrant Having a Right to Stk Dividends >AIM - 富途牛牛
AIM ImmunoTech Announces Stock Dividend - The Manila Times
AIM ImmunoTech to give extra shares to investors via stock dividend - Stock Titan
AIM ImmunoTech receives NYSE American notice of delisting and appeal - MSN
Published on: 2025-12-21 18:10:19 - Улправда
Why AIM ImmunoTech Inc. (HXB) stock is a must watch tickerPortfolio Value Report & Stepwise Entry/Exit Trade Alerts - Улправда
How AIM ImmunoTech Inc. (HXB) stock performs during market turbulenceJuly 2025 Recap & Trade Opportunity Analysis Reports - DonanımHaber
Will AIM ImmunoTech Inc. stock benefit from sector leadershipRate Cut & Real-Time Price Movement Reports - DonanımHaber
Published on: 2025-12-19 13:37:56 - Улправда
AIM ImmunoTech Completes 2025 Annual Stockholder Meeting - TipRanks
[8-K] AIM ImmunoTech Inc. Reports Material Event | AIM SEC FilingForm 8-K - Stock Titan
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B - Benzinga
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B - Sahm
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B (2025-12-16) - Seeking Alpha
AIM ImmunoTech Announces Release of the Next CEO Corner Segment - Yahoo Finance
Ascendiant Capital Maintains AIM ImmunoTech (AIM) Buy Recommendation - Nasdaq
Ascendiant Capital lowers AIM ImmunoTech stock price target to $22 on valuation - Investing.com Nigeria
Ascendiant Capital lowers AIM ImmunoTech stock price target to $22 on valuation By Investing.com - Investing.com South Africa
AIM: Analyst Maintains 'Buy' Rating, Lowers Price Target | AIM S - GuruFocus
Would You Still Hold AIM ImmunoTech Stock If It Fell Another 30%? - Trefis
How AIM ImmunoTech Inc. stock compares with tech leadersEarnings Recap Summary & Growth-Oriented Investment Plans - Newser
Will AIM ImmunoTech Inc. stock benefit from Fed rate cutsMarket Trend Report & Free Technical Confirmation Trade Alerts - Newser
How AIM ImmunoTech Inc. stock reacts to new regulations2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Will AIM ImmunoTech Inc. stock deliver compounding returnsJuly 2025 Earnings & Daily Risk Controlled Trade Plans - Newser
Can AIM ImmunoTech Inc. stock expand revenue streamsDollar Strength & Fast Moving Stock Trade Plans - Newser
AIM ImmunoTech (NYSEAMERICAN:AIM) Cut to Hold at Zacks Research - Defense World
Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosJuly 2025 Setups & Free Accurate Trade Setup Notifications - Newser
Why AIM ImmunoTech Inc. stock fits value portfoliosQuarterly Market Summary & Verified Momentum Watchlists - Newser
Can AIM ImmunoTech Inc. (HXB) stock sustain margin levels2025 Institutional Moves & Fast Exit and Entry Trade Guides - Newser
Is AIM ImmunoTech Inc. stock supported by strong fundamentals - Newser
AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series - The Manila Times
An analyst sees good growth prospects for AIM ImmunoTech Inc (AIM) - setenews.com
Published on: 2025-11-27 17:32:11 - moha.gov.vn
AIM ImmunoTech Inc. (AIM) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
AIM ImmunoTech Inc. (AIMI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
AIMAIM ImmunoTech Inc Forecast, Target Price - Finviz
What analyst consensus implies for AIM ImmunoTech Inc. (HXB) stock2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Why global investors buy AIM ImmunoTech Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Will AIM ImmunoTech Inc. (HXB) stock deliver stable dividends2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
How AIM ImmunoTech Inc. (HXB) stock behaves under inflation pressureMarket Movers & Real-Time Chart Breakout Alerts - newser.com
Is AIM ImmunoTech Inc. (HXB) stock vulnerable to rate hikesQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Can AIM ImmunoTech Inc. stock deliver strong annual returnsJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):